A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study. (Q53735140)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study. |
scientific article |
Statements
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study. (English)
1 reference
Susan M Blaney
1 reference
Terzah M Horton
1 reference
Debananda Pati
1 reference
Sharon E Plon
1 reference
Patrick A Thompson
1 reference
Lisa R Bomgaars
1 reference
Peter C Adamson
1 reference
Ashish M Ingle
1 reference
John Wright
1 reference
Adam H Brockman
1 reference
Martin Paton
1 reference
1 March 2007
1 reference
13
1 reference
5
1 reference
1516-1522
1 reference
Identifiers
1 reference